248 related articles for article (PubMed ID: 4047338)
1. Spontaneous sparsely-granulated prolactin-producing pituitary adenomas in aging rats. A prospective study of the effect of bromocriptine.
McComb DJ; Hellmann P; Kovacs K; Scott D; Evans WS; Burdman JA; Thorner MO
Neuroendocrinology; 1985 Sep; 41(3):201-11. PubMed ID: 4047338
[TBL] [Abstract][Full Text] [Related]
2. Morphologic effects of bromocriptine on spontaneously occurring pituitary prolactin-cell hyperplasia in old Long-Evans rats.
McComb DJ; Hellmann P; Thorner MO; Scott D; Evans WS; Kovacs K
Am J Pathol; 1986 Jan; 122(1):7-16. PubMed ID: 3942200
[TBL] [Abstract][Full Text] [Related]
3. Antitumor effect of bromocriptine on estrogen-induced rat prolactinomas: ultrastructural alterations of secretory granules.
Saitoh Y; Koizumi K; Arita N; Hayakawa T; Mogami H; Matsumoto K; Mori H
Anticancer Res; 1986; 6(5):1149-55. PubMed ID: 3800323
[TBL] [Abstract][Full Text] [Related]
4. Cytosuppressive effect of bromocriptine on human prolactinomas: stereological analysis of ultrastructural alterations with special reference to secretory granules.
Saitoh Y; Mori S; Arita N; Hayakawa T; Mogami H; Matsumoto K; Mori H
Cancer Res; 1986 Mar; 46(3):1507-12. PubMed ID: 3943108
[TBL] [Abstract][Full Text] [Related]
5. Ultrastructural morphometry of sparsely granulated prolactin cell adenomas of the human pituitary.
McComb DJ; Kovacs K
Acta Endocrinol (Copenh); 1978 Nov; 89(3):521-9. PubMed ID: 707008
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical, electron microscopic and morphometric studies of estrogen-induced rat prolactinomas after bromocriptine treatment.
Niwa J; Minase T; Hashi K; Mori M
Virchows Arch B Cell Pathol Incl Mol Pathol; 1987; 53(2):89-96. PubMed ID: 2887062
[TBL] [Abstract][Full Text] [Related]
7. In vitro short-term effects of SMS 201-995, bromocriptine and TRH on growth hormone cell morphology from human pituitary adenomas.
García García J; Jiménez Reina L; García Luna PP; Leal Cerro A; Astorga Jiménez R; García García-Revillo J; Bernal Valls G
Histol Histopathol; 1989 Apr; 4(2):223-33. PubMed ID: 2520459
[TBL] [Abstract][Full Text] [Related]
8. Effect of tamoxifen administration on prolactin release by invasive prolactin-secreting pituitary adenomas.
Lamberts SW; Verleun T; Oosterom R
Neuroendocrinology; 1982; 34(5):339-42. PubMed ID: 7078703
[TBL] [Abstract][Full Text] [Related]
9. Immunoelectron microscopy for growth hormone and prolactin in pituitary adenomas.
Tomita T; Watanabe I; Rengachary SS
Hum Pathol; 1987 Apr; 18(4):367-74. PubMed ID: 3549533
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical expression of SNAP-25 protein in adenomas of the human pituitary.
Rotondo F; Kovacs K; Scheithauer BW; Horvath E; Bell CD; Lloyd RV; Cusimano M
Appl Immunohistochem Mol Morphol; 2008 Oct; 16(5):477-81. PubMed ID: 18633321
[TBL] [Abstract][Full Text] [Related]
11. Hyperprolactinemic response after bromocriptine withdrawal in women with prolactin-secreting pituitary tumors.
Maxson WS; Dudzinski M; Handwerger SH; Hammond CB
Fertil Steril; 1984 Feb; 41(2):218-23. PubMed ID: 6698215
[TBL] [Abstract][Full Text] [Related]
12. Effect of dopamine agonist medication on prolactin producing pituitary adenomas. A morphological study including immunocytochemistry, electron microscopy and in situ hybridization.
Kovacs K; Stefaneanu L; Horvath E; Lloyd RV; Lancranjan I; Buchfelder M; Fahlbusch R
Virchows Arch A Pathol Anat Histopathol; 1991; 418(5):439-46. PubMed ID: 2035258
[TBL] [Abstract][Full Text] [Related]
13. Spontaneous pituitary adenomas in aging rats. A light microscopic, immunocytological and fine structural study.
Kovacs K; Horvath E; Ilse RG; Ezrin C; Ilse D
Beitr Pathol; 1977 Sep; 161(1):1-16. PubMed ID: 336031
[TBL] [Abstract][Full Text] [Related]
14. In vivo effect of cabergoline, a dopamine agonist, on estrogen-induced rat pituitary tumors.
Eguchi K; Kawamoto K; Uozumi T; Ito A; Arita K; Kurisu K
Endocr J; 1995 Apr; 42(2):153-61. PubMed ID: 7627259
[TBL] [Abstract][Full Text] [Related]
15. Bromocriptine effects on cultured human prolactin-producing pituitary adenomas: in vitro ultrastructural, morphometric, and immunoelectron microscopic studies.
Hassoun J; Jaquet P; Devictor B; Andonian C; Grisoli F; Gunz G; Toga M
J Clin Endocrinol Metab; 1985 Oct; 61(4):686-92. PubMed ID: 4031013
[TBL] [Abstract][Full Text] [Related]
16. Bromocriptine treatment reduces the cell size in human macroprolactinomas: a morphometric study.
Bassetti M; Spada A; Pezzo G; Giannattasio G
J Clin Endocrinol Metab; 1984 Feb; 58(2):268-73. PubMed ID: 6693536
[TBL] [Abstract][Full Text] [Related]
17. Effects of chronic bromocriptine treatment of an estrone-induced, prolactin-secreting rat pituitary adenoma.
Eljarmak D; Lis M; Cantin M; Carrière PD; Collu R
Horm Res; 1985; 21(3):160-7. PubMed ID: 3997065
[TBL] [Abstract][Full Text] [Related]
18. Prolactin receptor messenger ribonucleic acid in normal and neoplastic human pituitary tissues.
Jin L; Qian X; Kulig E; Scheithauer BW; Calle-Rodrigue R; Abboud C; Davis DH; Kovacs K; Lloyd RV
J Clin Endocrinol Metab; 1997 Mar; 82(3):963-8. PubMed ID: 9062514
[TBL] [Abstract][Full Text] [Related]
19. Heterogeneity of secretory granules of silent pituitary adenomas.
Holck S; Wewer UM; Albrechtsen R
Mod Pathol; 1988 May; 1(3):212-5. PubMed ID: 3237702
[TBL] [Abstract][Full Text] [Related]
20. Human pituitary somatotroph adenoma and prolactinoma: an ultrastructural and immunoelectron microscopical study.
Zhou XJ; Zhang TH; Yu YQ; Wang FA
J Tongji Med Univ; 1990; 10(2):83-7. PubMed ID: 2213957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
